» Articles » PMID: 28827520

Platelets Reduce Anoikis and Promote Metastasis by Activating YAP1 Signaling

Abstract

Thrombocytosis is present in more than 30% of patients with solid malignancies and correlates with worsened patient survival. Tumor cell interaction with various cellular components of the tumor microenvironment including platelets is crucial for tumor growth and metastasis. Although it is known that platelets can infiltrate into tumor tissue, secrete pro-angiogenic and pro-tumorigenic factors and thereby increase tumor growth, the precise molecular interactions between platelets and metastatic cancer cells are not well understood. Here we demonstrate that platelets induce resistance to anoikis in vitro and are critical for metastasis in vivo. We further show that platelets activate RhoA-MYPT1-PP1-mediated YAP1 dephosphorylation and promote its nuclear translocation which induces a pro-survival gene expression signature and inhibits apoptosis. Reduction of YAP1 in cancer cells in vivo protects against thrombocytosis-induced increase in metastasis. Collectively, our results indicate that cancer cells depend on platelets to avoid anoikis and succeed in the metastatic process.Platelets have been associated with increased tumor growth and metastasis but the mechanistic details of this interaction are still unclear. Here the authors show that platelets improve anoikis resistance of cancer cells and increase metastasis by activating Yap through a RhoA/MYPT-PP1 pathway.

Citing Articles

Molecular Underpinnings of Brain Metastases.

Jacome M, Wu Q, Chen J, Mohamed Z, Mokhtari S, Pina Y Int J Mol Sci. 2025; 26(5).

PMID: 40076927 PMC: 11900073. DOI: 10.3390/ijms26052307.


The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy.

Morales-Pacheco M, Valenzuela-Mayen M, Gonzalez-Alatriste A, Mendoza-Almanza G, Cortes-Ramirez S, Losada-Garcia A Biomark Res. 2025; 13(1):27.

PMID: 39934930 PMC: 11818056. DOI: 10.1186/s40364-025-00742-w.


Protein serine/threonine phosphatases in tumor microenvironment: a vital player and a promising therapeutic target.

Liu Y, Xia F, Zhu C, Song J, Tang B, Zhang B Theranostics. 2025; 15(3):1164-1184.

PMID: 39776803 PMC: 11700861. DOI: 10.7150/thno.104529.


Emerging advances in drug delivery systems (DDSs) for optimizing cancer complications.

Li K, Guo B, Gu J, Ta N, Gu J, Yu H Mater Today Bio. 2025; 30:101375.

PMID: 39759851 PMC: 11699619. DOI: 10.1016/j.mtbio.2024.101375.


Involvement of platelet signaling pathways in colorectal cancer and new therapeutic targets.

Bonfitto P, Rodrigues B, Siqueira N, Genaro L, Rodrigues B, Oliveira P Am J Cancer Res. 2024; 14(11):5133-5153.

PMID: 39659922 PMC: 11626285. DOI: 10.62347/PJNU8987.


References
1.
Klement G, Yip T, Cassiola F, Kikuchi L, Cervi D, Podust V . Platelets actively sequester angiogenesis regulators. Blood. 2008; 113(12):2835-42. PMC: 2661866. DOI: 10.1182/blood-2008-06-159541. View

2.
Steeg P . Targeting metastasis. Nat Rev Cancer. 2016; 16(4):201-18. PMC: 7055530. DOI: 10.1038/nrc.2016.25. View

3.
Jin H, Sperka T, Herrlich P, Morrison H . Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase. Nature. 2006; 442(7102):576-9. DOI: 10.1038/nature04856. View

4.
Virshup D, Shenolikar S . From promiscuity to precision: protein phosphatases get a makeover. Mol Cell. 2009; 33(5):537-45. DOI: 10.1016/j.molcel.2009.02.015. View

5.
Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills G . Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther. 2006; 5(10):2512-21. DOI: 10.1158/1535-7163.MCT-06-0334. View